Gradient Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Gradient Investments’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-116	Closed	-$6K	–	1238
2017 Q4	$6K	Buy	+116	New	+$6.35K	﹤0.01%	682
2017 Q3	–	Sell	-127	Closed	-$8K	–	829
2017 Q2	$8K	Hold	127	–	–	﹤0.01%	527
2017 Q1	$7K	Buy	+127	New	+$6.26K	﹤0.01%	576

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Gradient Investments's BIVV Position: Q1 2018 in Review

Gradient Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 116 shares — an estimated $6K sold.

Gradient Investments first reported a position in BIVV in Q1 2017 and held it in 3 quarters. The position peaked at $8K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Gradient Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Gradient Investments sold 116 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $6K.
Gradient Investments first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 3 quarters.
Gradient Investments's Bioverativ Inc. Common Stock position peaked at $8K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Gradient Investments's 13F filing for Q1 2018, filed 11 Apr 2018.